IRIS
CALABRESE, EMMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.577
EU - Europa 2.437
AS - Asia 1.265
SA - Sud America 40
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 7
OC - Oceania 4
Totale 31.339
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.561
SG - Singapore 737
CN - Cina 385
IT - Italia 374
UA - Ucraina 370
DE - Germania 367
IE - Irlanda 356
SE - Svezia 254
RU - Federazione Russa 178
FR - Francia 146
GB - Regno Unito 124
FI - Finlandia 112
KR - Corea 79
BE - Belgio 44
BR - Brasile 31
CZ - Repubblica Ceca 28
PL - Polonia 27
NL - Olanda 19
CA - Canada 13
IN - India 13
JP - Giappone 13
DK - Danimarca 7
EU - Europa 7
ID - Indonesia 7
ES - Italia 6
KG - Kirghizistan 6
VN - Vietnam 5
CH - Svizzera 4
EG - Egitto 4
HK - Hong Kong 4
RO - Romania 4
AR - Argentina 3
AT - Austria 3
GR - Grecia 3
HR - Croazia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AU - Australia 2
BG - Bulgaria 2
DM - Dominica 2
EC - Ecuador 2
IL - Israele 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
TN - Tunisia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 31.339
Salva come PNG Salva come JPEG
Città #
Woodbridge 8.119
Wilmington 6.844
Houston 6.802
Fairfield 953
Ann Arbor 837
Singapore 638
Chandler 491
Ashburn 428
Seattle 417
Cambridge 336
Jacksonville 323
Dublin 320
Medford 243
Dearborn 185
Rome 171
Santa Clara 161
Beijing 120
Lawrence 114
New York 91
Zhengzhou 80
San Diego 67
Brussels 44
Menlo Park 41
Mülheim 36
Moscow 34
Helsinki 29
Milan 28
Kraków 24
Boardman 23
Shanghai 23
Redwood City 21
Norwalk 20
Munich 18
Brno 17
Council Bluffs 16
Palo Alto 16
Nanjing 14
Verona 14
Hefei 13
London 13
University Park 13
Mountain View 11
Seoul 11
Kilburn 10
Kunming 10
Lappeenranta 10
Olomouc 10
Cedarhurst 9
San Mateo 9
Saint Petersburg 8
West Jordan 8
Changsha 7
Falls Church 7
Jakarta 7
Jinan 7
Los Angeles 7
San Francisco 7
Wuhan 7
Manitou Springs 6
Shenyang 6
Toronto 6
Amsterdam 5
Copenhagen 5
Creede 5
Guangzhou 5
Hangzhou 5
Hanover 5
Nanchang 5
Catania 4
Columbus 4
Del Norte 4
Durham 4
Fuzhou 4
Nürnberg 4
Phoenix 4
San Jose 4
São Paulo 4
Tokyo 4
Ancona 3
Anzio 3
Auburn Hills 3
Augsburg 3
Bologna 3
Boston 3
Cairo 3
Chennai 3
Chicago 3
Chongqing 3
Detroit 3
Dong Ket 3
Frosinone 3
Gravina In Puglia 3
Hebei 3
Hounslow 3
Indiana 3
Miami Beach 3
Nuremberg 3
Sannazzaro de' Burgondi 3
Trieste 3
Acton 2
Totale 28.500
Salva come PNG Salva come JPEG
Nome #
Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up 481
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis 481
ATG16L1 Ala197Thr Is Not Associated With Susceptibility to Crohn's Disease or With Phenotype in an Italian Population 466
Local injection of infliximab in the postoperative recurrence of Crohn's disease 463
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 447
Cancer and immunomodulators in inflammatory bowel diseases 445
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: relationship with colonic metaplasia 443
Surgery for fistula-in-ano in a specialist colorectal unit: a critical appraisal 438
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 438
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 434
Infliximab and newly diagnosed neoplasia in Crohn's disease: A multicentre matched pair study 433
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 432
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study 428
A family study of asymptomatic small bowel Crohn's disease 426
Planck 2013 results. I. Overview of products and scientific results 424
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 421
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study 419
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: a prospective longitudinal study 416
Steroid-free remission and closure of recto-vaginal fistula using adalimumab in a Crohn's disease patient naïve to anti-tumour necrosis factor alpha antibodies 416
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 414
Accuracy of Small Intestine Contrast Ultrasonography, Compared to Computed Tomography Enteroclysis, in Characterizing Lesions in Patients with Crohn's Disease. 413
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: A prospective longitudinal study 412
Colonic Phenotype of the Ileum in Crohn's Disease: A Prospective Study Before and after Ileocolonic Resection. 412
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study 411
Planck 2013 results. XV. CMB power spectra and likelihood 410
null 409
Measuring disease activity in Crohn's disease 409
Is It Always Necessary to Treat CD Patients? 408
Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease 406
Ultrasound in Crohns Disease 406
Small intestine contrast ultrasonography vs computed tomography enteroclysis for assessing ileal Crohn's disease. 406
Treatment with biologic therapies and the risk of cancer in patients with IBD. 406
Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: A novel recognizable microdeletion syndrome? 406
Frequency, pattern, and risk factors of postoperative recurrence of Crohn's disease after resection different from ileo-colonic 404
Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease 404
Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study 403
Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases 401
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease 400
Wireless capsule endoscopy and proximal small bowel lesions in Crohn's disease. 396
Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study 396
Frequency, Pattern, and Risk Factors of Postoperative Recurrence of Crohn's Disease After Resection Different from Ileo-Colonic 393
Wireless capsule endoscopy in Crohn’s disease: clinical relevance of upper GI lesions and feasibility 2 years after ileo-colonic resection. 388
Ala197Thr is not associated with susceptibility to Crohn’s Disease or with phenotype in an Italian population. 385
Capsule endoscopy and proximal small bowel lesions in patients with Crohn’s disease. 379
Bowel Ultrasonography for Timely Diagnosis of Intestinal Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation 379
Evolution of the Lesions Related to Crohn's Disease Recurrence As Assessed By Ultrasonography: A Prospective Longitudinal Study. 379
Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease 374
Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's disease. 373
A Sonographic Lesion Index for Crohn's Disease Helps Monitor Changes in Transmural Bowel Damage During Therapy 371
Comparison between techniques providing the luminal vs extraluminal surface in assessing Crohn’s disease recurrance: a prospective longitudinal study. 370
Antisense approach to inflammatory bowel disease: Prospects and challenges 369
In Crohn's Disease Colonic Mucins Are Expressed in the Established Ileal Lesions at Surgery While heal Mucins Are Mainly Expressed in the Early Ileal Recurrence: A Prospective Longitudinal Study 368
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis? 360
Planck 2013 results. XXII. Constraints on inflation 357
Diagnostic role of wireless capsule endoscopy in patients with symptoms highly compatible with Crohn's disease 355
Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis 354
Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case–control IG-IBD study 353
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease 352
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease 347
Ileal lesions in patients with Ulcerative Colitis after ileo-rectal anastomosis: relationship with colonic metaplasia. 342
Severity of Crohn’s disease recurrence after ileo-colon resection: correlation between endoscopic score and sonographic findings. 341
Malattia di Crohn. In: Malattie del canale digerente. Gasbarrini G, Morelli A. 337
New biologic therapies in patients with Inflammatory Bowel Disease [Nuovi farmaci biologici nelle Malattie Infiammatorie Croniche Intestinali] 333
Ultrasound of the small bowel in Crohn's disease 333
Laparoscopic versus open ileo-colonic resection in Crohn's disease: short- and long-term results from a prospective longitudinal study 329
Cancer in Infliximab treated or untreated Crohn’s disease patients: a 2 years longer follow up from a multicenter matched-pair study.. 325
Assessment of Crohn’s disease recurrence after Ileo-colonic resection: correlation between endoscopic score and sonographic findings. 319
Endoscopic vs ultrasonographic findings related to Crohn's disease recurrence: a prospective longitudinal study at 3 years. 313
Newly diagnosed neoplasia in a cohort of Crohn’s disease patients treated with Infliximab: a 3 years longer follow up from a multicenter matched-pair study. 308
Post-operative recurrence of Crohn's disease: A prospective study at 5 years. 303
Severity of postoperative recurrence in Crohn's disease: correlation between endoscopic and sonographic findings 298
Malattia di Crohn. In: Malattie del canale digerente 267
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 266
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 226
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 208
EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound 168
Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease 164
Extent of mucosal inflammation in ulcerative colitis influences the clinical remission induced by vedolizumab 163
Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts. 137
1 135
Fecal and mucosal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease 133
Response assessed by Ultrasonography as Target of Biological Treatment for Crohn's disease: Treat to target in CD using Ultrasonography 129
Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter Study. 127
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 111
Hepatic follicular lymphoma in an old patient with Crohn’s disease: a rare case and review of the literature 101
High frequency of undiagnosed psychiatric disorders in inflammatory bowel diseases 90
The impact of COVID-19 pandemic in the colorectal cancer prevention 87
ECCO-ESGAR guideline for diagnostic assessment in ibd part 2: Ibd scores and general principles and technical aspects 84
Crohn's disease: A comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema 57
Post-operative recurrence of Crohn's disease: A prospective study at 5 years 56
Impact of intestinal ultrasound on the management of patients with inflammatory bowel disease: how to apply scientific evidence to clinical practice 56
Why do we Still Use 5-ASAs in Crohn's Disease? 55
Treatment with biologic therapies and the risk of cancer in patients with IBD 55
Onset of ulcerative colitis during SARS-Cov-2 infection 53
EFSUMB Gastrointestinal Ultrasound (GIUS) Task Force Group: Celiac sprue and other rare gastrointestinal diseases ultrasound features 51
Efficacy and tolerability of very low-volume bowel preparation in patients with inflammatory bowel diseases 51
EFSUMB Recommendations and Clinical Guidelines for Intestinal Ultrasound (GIUS) in Inflammatory Bowel Diseases 48
EFSUMB Position Paper: Recommendations for Gastrointestinal Ultrasound (GIUS) in Acute Appendicitis and Diverticulitis 46
Concept design of the LiteBIRD satellite for CMB B-mode polarization 46
Effect of Vedolizumab on anemia of chronic disease in patients with inflammatory bowel diseases 45
Totale 30.985
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.509
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.810 0 0 0 0 0 861 685 673 707 665 671 548
2020/20215.421 577 655 542 629 510 606 784 534 108 178 214 84
2021/20221.450 54 146 75 122 84 102 72 71 221 119 66 318
2022/20231.348 165 101 22 170 129 339 122 70 114 7 74 35
2023/2024532 58 17 37 16 63 129 38 48 5 22 7 92
2024/20251.637 94 740 381 218 80 124 0 0 0 0 0 0
Totale 31.880